An interventional study of Meperidine in Postoperative Pain After Arthroscopic Knee Surgery, sponsored by Istanbul Medipol University Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-27.
Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Istanbul Medipol University Hospital.
Among the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital, this one is the 10th largest by planned enrollment, is one of 2 that started in 2026, is one of 12 with no phase, and was the 11th registered.
5,662 studies on the registry are indexed under Pain, Postoperative; 1,238 are open to participants now.
Browse Pain, Postoperative studies →4 of the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital are open now, in 1 country. Recruiting first, the newest first:
Istanbul Medipol University Hospital · Sites in Turkey
Ages 18–65
Istanbul Medipol University Hospital · Sites in Turkey
Ages 18–65
Istanbul Medipol University Hospital
Ages 18–65
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 75 across 4,841 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 13 interventional studies. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istanbul Medipol University Hospital is the lead sponsor of 368 studies on the registry; 48 are open to participants now.
1 of the studies in Pain, Postoperative by Istanbul Medipol University Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07790393Istanbul Medipol University HospitalAdductor Canal Block Versus Parasartorial Compartment Block for Pain Relief and Recovery After Arthroscopic Knee Surgery | 2027-06 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to compare adductor canal block and parasartorial compartment block for pain relief and functional recovery in adults undergoing elective arthroscopic knee surgery. The main questions it aims to answer are:
Which block provides better pain relief at rest and during movement 24 hours after surgery? How do the two blocks compare in opioid use, muscle strength, knee movement, early walking, side effects, and patient satisfaction?
Researchers will compare participants who receive an adductor canal block with those who receive a parasartorial compartment block to determine whether one technique provides better pain relief and functional recovery while preserving muscle strength.
Participants will:
Be randomly assigned to receive either an ultrasound-guided adductor canal block or an ultrasound-guided parasartorial compartment block Have their pain at rest and during knee movement assessed for 48 hours after surgery Have their opioid use, quadriceps muscle strength, knee movement, walking ability, side effects, and satisfaction evaluated after surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Meperidine
Drug: Meperidine
If the patient's NRS is 4 or more, 0.5 mg/kg meperidine will be given
Pain at Rest 24 Hours After Surgery
Pain intensity at rest will be assessed using the Numeric Rating Scale, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Lower scores indicate less pain.
Time frame: 24 hours
Plan to share: No — Individual participant data will not be publicly shared because the informed consent process does not include consent for public data sharing and to protect participant confidentiality. Aggregated study results will be reported in scientific publications.
Start is estimated for Sep 2026; primary completion for Jun 2027, 9 months later.
Of 2,101 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.
Counting every sponsor, half of 2,114 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Meperidine
Istanbul Medipol University Hospital →